INTERACTION BETWEEN ONCOSTATIN-M, INTERLEUKIN-1 AND PROSTAGLANDIN E(2) IN INDUCTION OF IL-6 EXPRESSION IN HUMAN FIBROBLASTS

被引:39
作者
RICHARDS, CD
AGRO, A
机构
[1] Molecular Virology and Immunology Programme, Department of Pathology, McMaster University
关键词
ONCOSTATIN M; INTERLEUKIN; 6; FIBROBLASTS;
D O I
10.1016/1043-4666(94)90006-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of Oncostatin M (OM), a monocyte/macrophage and T-cell product, in regulating IL-6 expression in fibroblasts of lung or synovial origin was examined in vitro. Although by itself OM had a minimal effect on enhancing IL-6 production by fibroblasts, in combination with IL-1α or PGE2, OM addition resulted in a dose-dependent synergistic enhancement of IL-6 production. This synergistic effect with either IL-1α (5 ng/ml) or PGE2 (10-7 M) was clearly evident at concentrations of OM of 10, 20 or 50 ng/ml. Levels of IL-6 resulting from OM and IL-1α stimulation could be reduced by indomethacin (10-6 M) and restored again by also adding PGE2. Northern blots probed for IL-6 mRNA showed cooperative enhancement of steady state levels at 18 hours of stimulation by OM and IL-1α, or OM and PGE2. Probing for mRNA of the metalloproteinase inhibitor TIMP-1 showed that stimulation by OM, IL-1α or PGE2 enhanced TIMP-1 levels. However, OM (alone) or PGE2 or both combined did not elevate the metalloproteinase stromelysin-1 mRNA signals. Analysis utilizing a rat IL-6 promoter-luciferase reporter gene construct showed that OM stimulation resulted in activation of transcription that synergistically enhanced IL-1-induced levels of reporter gene expression. These results show that although OM has minor effects on IL-6 production alone, the combination of OM and other mediators result in markedly enhanced IL-6 production by fibroblasts in vitro. © 1994 Academic Press Limited.
引用
收藏
页码:40 / 47
页数:8
相关论文
共 60 条
[1]   PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES [J].
AARDEN, LA ;
DEGROOT, ER ;
SCHAAP, OL ;
LANSDORP, PM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1411-1416
[2]   CYTOKINES AND CYTOKINE INHIBITORS OR ANTAGONISTS IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1990, 33 (03) :305-315
[3]  
BAFFET G, 1991, MOL BIOL MED, V8, P141
[4]   MURINE INTERLEUKIN-1 RECEPTOR - DIFFERENCES IN BINDING-PROPERTIES BETWEEN FIBROBLASTIC AND THYMOMA CELLS AND EVIDENCE FOR A 2-CHAIN RECEPTOR MODEL [J].
BIRD, TA ;
GEARING, AJH ;
SAKLATVALA, J .
FEBS LETTERS, 1987, 225 (1-2) :21-26
[5]   EVIDENCE THAT MAP (MITOGEN-ACTIVATED PROTEIN) KINASE ACTIVATION MAY BE A NECESSARY BUT NOT SUFFICIENT SIGNAL FOR A RESTRICTED SUBSET OF RESPONSES IN IL-1-TREATED EPIDERMOID CELLS [J].
BIRD, TA ;
SCHULE, HD ;
DELANEY, PB ;
SIMS, JE ;
THOMA, B ;
DOWER, SK .
CYTOKINE, 1992, 4 (06) :429-440
[6]   IDENTIFICATION OF A COMMON CLASS OF HIGH-AFFINITY RECEPTORS FOR BOTH TYPES OF PORCINE INTERLEUKIN-1 ON CONNECTIVE-TISSUE CELLS [J].
BIRD, TA ;
SAKLATVALA, J .
NATURE, 1986, 324 (6094) :263-266
[7]  
BROWN TJ, 1991, J IMMUNOL, V147, P2175
[8]  
BROWN TJ, 1987, J IMMUNOL, V139, P2977
[9]  
BRUCE AG, 1992, J IMMUNOL, V149, P1271
[10]  
BUTLER DM, 1988, J RHEUMATOL, V15, P1463